Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial. [electronic resource]
Producer: 20191030Description: e328-e337 p. digitalISSN:- 2352-3026
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cyclophosphamide -- administration & dosage
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Neoplasm Grading
- Neutropenia -- etiology
- Proportional Hazards Models
- Rituximab -- administration & dosage
- Survival Rate
- Treatment Outcome
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.